(Q35635601)

9 August 2017

title

Prerequisites to implementing a pharmacogenomics program in a large health-care system (English)

1 reference

9 August 2017

1 reference

K D Levy

1

1 reference

9 August 2017

B S Decker

2

1 reference

9 August 2017

J S Carpenter

3

1 reference

9 August 2017

D A Flockhart

4

1 reference

9 August 2017

P R Dexter

5

1 reference

9 August 2017

Z Desta

6

1 reference

9 August 2017

T C Skaar

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

7 May 2014

1 reference

Clinical Pharmacology & Therapeutics

9 August 2017

published in

1 reference

9 August 2017

volume

96

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

307-309

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2014.101

9 August 2017

exact match

0 references

cites work

Pharmacogenetics in clinical practice: how far have we come and where are we going?

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4441093

Implications of the Human Genome Project for medical science.

27 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FCLPT.2014.101

Limitations of direct-to-consumer advertising for clinical genetic testing

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FCLPT.2014.101

A framework to evaluate the economic impact of pharmacogenomics

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24807457

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/CLPT.2014.101

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference